Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933671 · ClinicalTrials.gov registry record · Phase 4
Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT02933671 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 11 participants.
The verdict
NCT02933671, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection technique (also called a "nerve block") that numbs the nerves going to the side and front of the upper leg will improve pain control after surgery. The SIFI technique uses a numbing solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This block may affect movement in the leg and make the legs weak. The amount of leg weakness is not known and assessment of this will be included in the study. Many institutions use the SIFI block for patients having total hip replacements, with the hope of providing good pain relief combined with improved mobility after surgery.
Interventions
- DRUG Saline
- DRUG Ropivacaine
- PROCEDURE Suprainguinal fascia iliaca (SIFI) block
- PROCEDURE Sham block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-03-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933671
The ClinicalTrials.gov registry entry for NCT02933671 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Saline is the first listed.
NCT02933671 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02933671 about?
NCT02933671 is a clinical study titled "Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty". The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection technique (also called a "nerve block") that numbs the nerves going to the side and front of the upper leg will improve pain control after surgery. The SIFI technique uses a numbing solution (local anesthet...
What is the current status of trial NCT02933671?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2017-08-01. Estimated completion is 2020-03-17.
What interventions are being tested in trial NCT02933671?
The interventions under investigation include: Saline (DRUG), Ropivacaine (DRUG), Suprainguinal fascia iliaca (SIFI) block (PROCEDURE), Sham block (PROCEDURE).
Who is sponsoring clinical trial NCT02933671?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.